Rutherford Health Plc
The three centres, based in Newport, South Wales, Bomarsund, Northumberland and at Reading, are the first to offer high energy proton beam therapy in the United Kingdom with the first patients having received PBT at the Group's oncology centre in Newport in April 2018.
| Symbol | Ccy Code | Bid | Ask | Mid | Previous Close | Volume | Last Traded |
|---|---|---|---|---|---|---|---|
| RUTH | GBX | 194 | 202 | 198 | 198 | 1000 | 29.03.21 |
MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.
Financial Information
| Last results date: 29.02.20 | |
|---|---|
| Enterprise Value | £398.33m |
| EV/EBITDA | (20.48) |
| EV/EBIT | (15.64) |
| PE Ratio | (16) |
| PEG | (0.21)% |
| Dividend Yield | - |
| Free Cash Yield | (13.71)% |
Click here to download a glossary of terms.
All data provided by Fregnan.
| 28.02.18 (£'000) |
28.02.19 (£'000) |
29.02.20 (£'000) |
|
|---|---|---|---|
| Income Statement | |||
| Revenue | 18 | 1,465 | 5,606 |
| Operating Income (EBIT) | (10,554) | (19,280) | (25,468) |
| Net Income | (8,679) | (18,265) | (24,434) |
| Balance Sheet | |||
| Cash | 6,695 | 20,589 | 19,157 |
| Total Debt | 13,149 | 24,515 | 10,586 |
| Total Liabilities | 24,967 | 52,690 | 26,530 |
| Total Equity | 94,014 | 118,410 | 167,513 |
| Operating Margin | (58,633.33)% | (1,316.04)% | (454.30)% |
| EPS - Basic | (7.53)p | (14.19)p | (14.22)p |
| EPS - Growth | - | 88.48% | 0.21% |
| Dividend Per Share | - | - | - |
| Average Shares Outstanding | 115.31m | 128.76m | 171.89m |
| ROA | - | (12.59%) | (13.38%) |
| ROCE | - | (15.42%) | (15.87%) |
| ROE | - | (17.20%) | (17.09%) |
Click here to download a glossary of terms.
All data provided by Fregnan.
| 28.02.18 (£'000) |
28.02.19 (£'000) |
29.02.20 (£'000) |
|
|---|---|---|---|
| Revenue | 18 | 1,465 | 5,606 |
| Cost of Revenue | - | 2,872 | 5,190 |
| Depreciation & Amortisation | 1,003 | 3,664 | 6,020 |
| Gross Profit | (985) | (5,071) | (5,604) |
| Other Operating Expenses | 9,569 | 14,209 | 19,864 |
| Operating Income (EBIT) | (10,554) | (19,280) | (25,468) |
| Net Interest Expense | 1,034 | 2,393 | 3,615 |
| Unusual Expense (incl. Exceptionals) | - | - | - |
| Non-Operating Expense | 77 | 155 | (193) |
| Profit (pre-tax) | (11,511) | (21,518) | (29,276) |
| Taxation | 2,832 | 3,253 | 4,842 |
| Other Expenses and Minortity Interest | - | - | - |
| Net Income | (8,679) | (18,265) | (24,434) |
Click here to download a glossary of terms.
All data provided by Fregnan.
| 28.02.18 (£'000) |
28.02.19 (£'000) |
29.02.20 (£'000) |
|
|---|---|---|---|
| Cash from Operations | (4,957) | 1,408 | (34,046) |
| Cash from Investing | (40,606) | (42,057) | (19,550) |
| Cash from Financing | 17,117 | 54,543 | 52,164 |
| Other Miscellaneous | - | - | - |
| Net Cash Flow | (28,446) | 13,894 | (1,432) |
Click here to download a glossary of terms.
All data provided by Fregnan.
| 28.02.18 (£'000) |
28.02.19 (£'000) |
29.02.20 (£'000) |
|
|---|---|---|---|
| Current Assets | 13,936 | 27,504 | 29,380 |
| Non-Current Assets | 105,045 | 143,596 | 164,663 |
| Total Assets | 118,981 | 171,100 | 194,043 |
| Current Liabilities | 11,818 | 28,175 | 15,944 |
| Non-Current Liabilities | 13,149 | 24,515 | 10,586 |
| Total Liabilities | 24,967 | 52,690 | 26,530 |
| Net Assets | 94,014 | 118,410 | 167,513 |
| Total Equity | 94,014 | 118,410 | 167,513 |
Click here to download a glossary of terms.
All data provided by Fregnan.
Address
Business Address
Rutherford Health plc, Suite 4 Penn House, 9-10 Broad Street, Hereford, HR4 9AP, United Kingdom.
Registered Address
15 Bridge Street, Hereford, HR4 9DF, United Kingdom.
Contacts
Corporate Adviser
Grant Thornton UK LLP., 30 Finsbury Square, London, United Kingdom.
Email: website.enquiries.general@uk.gt.com
Phone: 020 7383 5100
Registrar
Share Registrars Ltd, The Courtyard, 17 West Street, Farnham, Surrey, GU9 7DR, United Kingdom.
Email: enquiries@shareregistrars.uk.com
Phone: 01252 821390
Research
I'm sorry there is no research for this company.